Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have received an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $17.30.
AFYA has been the topic of several research reports. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday, January 16th. Bank of America cut shares of Afya from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Finally, Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 31st.
View Our Latest Stock Analysis on Afya
Institutional Trading of Afya
Afya Trading Down 1.1%
Shares of AFYA stock opened at $13.88 on Monday. Afya has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The firm’s 50 day moving average price is $14.46 and its two-hundred day moving average price is $14.79. The stock has a market cap of $1.30 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 0.63 and a beta of 0.52. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
- Five stocks we like better than Afya
- What a Former CIA Agent Knows About the Coming Collapse
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
- The Next Commodity Crunch (bigger than oil?)
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
